StockNews.com began coverage on shares of DexCom (NASDAQ:DXCM – Free Report) in a research report sent to investors on Thursday. The firm issued a hold rating on the medical device company’s stock. Several other research firms have also recently issued reports on DXCM. Piper Sandler raised their price target on DexCom from $150.00 to $160.00 […]